- Home
- HBNC vs RVPHW Comparison
HBNC vs RVPHW Comparison
Compare HBNC & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBNC
- RVPHW
- Stock Information
- Founded
- HBNC 1873
- RVPHW N/A
- Country
- HBNC United States
- RVPHW United States
- Employees
- HBNC N/A
- RVPHW 15
- Industry
- HBNC Major Banks
- RVPHW Biotechnology: Pharmaceutical Preparations
- Sector
- HBNC Finance
- RVPHW Health Care
- Exchange
- HBNC Nasdaq
- RVPHW Nasdaq
- Market Cap
- HBNC 648.7M
- RVPHW N/A
- IPO Year
- HBNC N/A
- RVPHW 2018
- Fundamental
- Price
- HBNC $14.66
- RVPHW $0.11
- Analyst Decision
- HBNC Hold
- RVPHW
- Analyst Count
- HBNC 3
- RVPHW 0
- Target Price
- HBNC $15.33
- RVPHW N/A
- AVG Volume (30 Days)
- HBNC 162.7K
- RVPHW N/A
- Earning Date
- HBNC 10-23-2024
- RVPHW N/A
- Dividend Yield
- HBNC 4.39%
- RVPHW N/A
- EPS Growth
- HBNC N/A
- RVPHW N/A
- EPS
- HBNC 0.43
- RVPHW N/A
- Revenue
- HBNC $179,998,000.00
- RVPHW N/A
- Revenue This Year
- HBNC N/A
- RVPHW N/A
- Revenue Next Year
- HBNC $7.84
- RVPHW N/A
- P/E Ratio
- HBNC $33.73
- RVPHW N/A
- Revenue Growth
- HBNC N/A
- RVPHW N/A
- 52 Week Low
- HBNC $9.22
- RVPHW N/A
- 52 Week High
- HBNC $16.64
- RVPHW N/A
- Technical
- Relative Strength Index (RSI)
- HBNC 41.08
- RVPHW N/A
- Support Level
- HBNC $14.63
- RVPHW N/A
- Resistance Level
- HBNC $14.83
- RVPHW N/A
- Average True Range (ATR)
- HBNC 0.41
- RVPHW 0.00
- MACD
- HBNC -0.12
- RVPHW 0.00
- Stochastic Oscillator
- HBNC 6.86
- RVPHW 0.00
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.